In recent developments, Simulations Plus (SLP, Financial) has seen its price target adjusted by analyst David Larsen from BTIG. The updated price target has been lowered from $41.00 to $25.00, indicating a significant decrease of 39.02%. Despite this downward revision, the rating for Simulations Plus (SLP) remains consistent as a 'Buy'.
Simulations Plus (SLP, Financial), known for its role in providing software for modeling and simulation in the pharmaceutical industry, continues to be under observation by market analysts. The decision to maintain the 'Buy' rating suggests confidence in the company's long-term potential, despite the revised price target.
Investors should note that the currency for this adjustment is in USD, and the details come as of July 7, 2025. The changes reflect BTIG's ongoing assessment of the company's market positioning and growth prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for Simulations Plus Inc (SLP, Financial) is $36.25 with a high estimate of $41.00 and a low estimate of $28.00. The average target implies an upside of 115.39% from the current price of $16.83. More detailed estimate data can be found on the Simulations Plus Inc (SLP) Forecast page.
Based on the consensus recommendation from 6 brokerage firms, Simulations Plus Inc's (SLP, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Simulations Plus Inc (SLP, Financial) in one year is $65.63, suggesting a upside of 289.96% from the current price of $16.83. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Simulations Plus Inc (SLP) Summary page.
